Florida International University
Adam Carrico, PhD
This Phase II randomized controlled trial is testing the efficacy of a cell phone application called START for helping men who use stimulants like methamphetamine to get the most out of their HIV treatment.
Adherence, Medication
HIV-1-infection
Stimulant Use
START mHealth Intervention
Not Applicable
Study Type : | Interventional |
Estimated Enrollment : | 350 participants |
Masking: | None (Open Label) |
Primary Purpose: | Other |
Official Title: | Supporting Treatment Adherence for Resilience and Thriving |
Actual Study Start Date : | June 15, 2022 |
Estimated Primary Completion Date : | October 31, 2024 |
Estimated Study Completion Date : | April 30, 2025 |
Arm | Intervention/treatment |
---|---|
Experimental: START mHealth Intervention Participants randomized to receive the START mHealth intervention will have access to the mHealth application for 6 months following randomization. |
|
No Intervention: Website referrals Participants in this condition will receive no intervention and will have access to a website with resources related to substance use disorder treatment and HIV treatment. |
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Recruiting
University of MIami Miller School of Medicine
Miami, Florida, United States, 33136